Brind.

Solvonis Therapeutics plc announced its AGM results and updated its clinical portfolio progress on the London Stock Exchange.

Steady: 0 in the last 7 days Updated oct 6

The latest in this situation

Barry Gibb chairs an investor webinar while David Nutt serves as Chief Scientific Officer for Solvonis Therapeutics plc.Oct 6

How it started

1 report, 1 independent, last reported Jun 19. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Solvonis Therapeutics plc announced its AGM results and updated its clinical portfolio progress on the London Stock Exchange.

Who's involved

What this event is mainly about

London Stock Exchange

How it developed

Newest first. Tap a step to see who reported it.

Oct 6Barry Gibb chairs an investor webinar while David Nutt serves as Chief Scientific Officer for Solvonis Therapeutics plc.Sub-event
Aug 11Solvonis Therapeutics plc announced that the United States is now its principal development and commercial market.Sub-event
Jun 19Solvonis Therapeutics plc reported AGM results and clinical portfolio updates.1 source
- investegate.co.uk

Keep exploring

The entities involved

London Stock Exchange
stock exchange in the City of London
- Petra Diamonds failed to publish its annual accounts on the London Stock Exchange.05:53
- An LSE representative attended the Africa Prosperity Summit, convened in Lagos, Egypt, involving African VC firms.Tue 16:19

Coverage

Newest first; wire copies grouped

Jun 19investegate.co.uk